Trials / Completed
CompletedNCT00863538
Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
An Open-label, Phase II Study of KPS-0373 in Patients With SCD
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy, safety and pharmacokinetics profile of KPS-0373 in patients with SCD
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KPS-0373 |
Timeline
- First posted
- 2009-03-18
- Last updated
- 2010-02-03
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00863538. Inclusion in this directory is not an endorsement.